Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-06-05a RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing ™
-
CLINICAL_TRIALS study record update · 2013-06-05A Phase I Clinical And Pharmacological Study Of Pyroxamide (NSC 696085) In Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2013-06-04A Phase II Study of Intensive-Dose Topotecan, Ifosfamide/Mesna and Etoposide (Vepesid)(TIME) Followed by Autologous Stem Cell Rescue in High Risk Lymphoma
-
CLINICAL_TRIALS study record update · 2013-06-04A Prospective, Comparative Trial of Allogeneic Versus Autologous Stem Cell Transplantation for High Risk Lymphoma
-
CLINICAL_TRIALS study record update · 2013-05-31A Randomized Study Of Electroacupuncture Treatment For Delayed Chemotherapy-Induced Nausea And Vomiting In Patients With Pediatric Solid Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-05-31Multicenter Phase II Study for Zevalin® in Patients With Relapsed/Refractory Indolent Lymphomas: Extranodal Marginal Lymphoma of MALT Type, Nodal Marginal Zone B-Cell Lymphoma, and Splenic Marginal B-Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2013-05-30Phase 1-2 Multi-Center Study of Intravenous BCX-1777 in Patients With Refractory Cutaneous T-Cell Lymphoma (CTCL)
-
CLINICAL_TRIALS study record update · 2013-05-30Phase I/II Open Label, Dose-Escalating Study of MDX-060 Administered Weekly for 4 Weeks in Patients With Refractory/Relapsed CD30 Lymphoma
-
CLINICAL_TRIALS study record update · 2013-05-30A Phase II Multicenter Study of Ontak® (Denileukin Diftitox) in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2013-05-30Phase I Study Of IDEC-152 (Anti-CD23 Monoclonal Antibody) In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia
-
CLINICAL_TRIALS study record update · 2013-05-30A Phase I Study of Temsirolimus in Combination With Metformin in Advanced Solid Tumours
-
CLINICAL_TRIALS study record update · 2013-05-30An Evaluation of Corticosteroid Pretreatment in Cutaneous T-Cell Lymphoma Patients Receiving Ontak (Denileukin Difitox)
-
CLINICAL_TRIALS study record update · 2013-05-20Central Lymphoma Repository Tissue Procurement Protocol
-
CLINICAL_TRIALS study record update · 2013-05-20Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
-
CLINICAL_TRIALS study record update · 2013-05-20Central Lymphoma Serum Repository Protocol
-
CLINICAL_TRIALS study record update · 2013-05-17A Phase II Study Of PS-341 (NSC 681239) In Patients With Untreated Or Relapsed Waldenstrom's Macroglobulinemia
-
CLINICAL_TRIALS study record update · 2013-05-16Candidate Gene Polymorphisms and Response to Rituximab-CHOP in Patients With Diffuse Large Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2013-05-15A Phase II Study of Hu1D10 in Recurrent Hodgkin's Disease
-
CLINICAL_TRIALS study record update · 2013-05-15A PHASE II TRIAL OF EIGHT-WEEK STANFORD V CHEMOTHERAPY PLUS MODIFIED INVOLVED FIELD RADIOTHERAPY IN FAVORABLE, LIMITED STAGE HODGKIN'S DISEASE
-
CLINICAL_TRIALS study record update · 2013-05-15A Phase I, Multiple Dose Escalation Trial of Intravenous Humanized Anti-CD3 Antibody (HuM291) in Patients With CD3+ T-cell Lymphomas
-
CLINICAL_TRIALS study record update · 2013-05-15@neWorld: A Virtual Community For Kids With Cancer
-
CLINICAL_TRIALS study record update · 2013-05-09Autologous Blood and Marrow Transplantation for Hematologic Malignancy and Selected Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-05-03A Phase II Trial of Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Peripheral Blood Stem Cells for Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2013-05-01The Quality of Life of Adult Survivors Who Received a Marrow Transplant as a Child
-
CLINICAL_TRIALS study record update · 2013-05-01A Phase I, Open-Label, Maximum Tolerated Single-Cycle and Four-Cycle Dose-Finding Study to Evaluation the Safety and Tolerability of 90Y-SMT 487 Administered by Intravenous Infusion to Subjects With Refractory Somatostatin-Receptor Positive Tumors